Bond Screener
Teligent
LEI 5493004O07DCTA44TG55
The issuer's bonds defaulted in 2021
Organization name
Teligent, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
0.28 mln USD
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Teligent, Inc. (formerly IGI Laboratories, Inc.), is a specialty generic pharmaceutical company. They develop, manufacture and market pharmaceutical products for use by doctors and patients in the United States and Canada.
|
General information
-
Organization nameTeligent, Inc.
-
Organization statusOperating organization
-
Address105 Lincoln Avenue Vineland, USA, 08360
-
Previous organization nameIGI Laboratories (to 22/10/2015)
IFRS/US GAAP reports
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show all
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameTeligent, Inc.
-
Organization statusOperating organization
-
Address105 Lincoln Avenue Vineland, USA, 08360
-
Previous organization nameIGI Laboratories (to 22/10/2015)
Codes
-
LEI5493004O07DCTA44TG55
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
CIK0000352998
